Summit Therapeutics, Inc. (SMMT)
15.47
-0.08
(-0.51%)
USD |
NASDAQ |
Oct 23, 16:00
15.48
+0.01
(+0.06%)
After-Hours: 20:00
Summit Therapeutics Price : 15.47 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 15.46 | 15.55 | 15.08 | 15.47 | 3.211M |
| Oct 22, 2026 | 15.29 | 15.70 | 15.13 | 15.55 | 4.151M |
| Oct 21, 2026 | 16.35 | 16.35 | 15.72 | 15.83 | 5.367M |
| Oct 20, 2026 | 15.50 | 16.18 | 15.06 | 16.09 | 6.253M |
| Oct 19, 2026 | 14.90 | 15.77 | 14.83 | 15.57 | 6.154M |
| Oct 16, 2026 | 15.39 | 15.41 | 14.56 | 14.63 | 4.331M |
| Oct 15, 2026 | 15.09 | 15.55 | 15.08 | 15.37 | 4.733M |
| Oct 14, 2026 | 15.29 | 15.56 | 15.04 | 15.13 | 4.662M |
| Oct 13, 2026 | 16.79 | 16.79 | 15.46 | 15.52 | 7.132M |
| Oct 12, 2026 | 17.48 | 17.59 | 17.05 | 17.13 | 4.376M |
| Oct 09, 2026 | 17.36 | 17.62 | 16.82 | 17.59 | 5.755M |
| Oct 08, 2026 | 17.61 | 17.64 | 16.80 | 17.17 | 6.179M |
| Oct 07, 2026 | 17.10 | 18.33 | 16.98 | 17.95 | 8.175M |
| Oct 06, 2026 | 17.49 | 17.53 | 16.53 | 17.31 | 5.876M |
| Oct 05, 2026 | 16.97 | 17.62 | 16.44 | 17.27 | 5.278M |
| Oct 02, 2026 | 16.96 | 17.32 | 16.66 | 16.76 | 5.196M |
| Oct 01, 2026 | 16.82 | 17.50 | 16.59 | 16.69 | 7.901M |
| Sep 30, 2026 | 16.59 | 17.72 | 16.17 | 16.91 | 13.06M |
| Sep 29, 2026 | 18.91 | 19.09 | 16.15 | 16.39 | 27.34M |
| Sep 28, 2026 | 15.50 | 15.82 | 15.18 | 15.48 | 6.151M |
| Sep 25, 2026 | 16.45 | 16.58 | 15.55 | 15.61 | 3.808M |
| Sep 24, 2026 | 16.37 | 16.78 | 16.09 | 16.38 | 5.045M |
| Sep 23, 2026 | 17.10 | 17.46 | 16.25 | 16.45 | 3.891M |
| Sep 22, 2026 | 16.97 | 17.50 | 16.79 | 17.12 | 4.617M |
| Sep 21, 2026 | 18.40 | 18.42 | 16.64 | 16.90 | 5.781M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| NovelStem International Corp. | 0.0066 |
| Brainstorm Cell Therapeutics, Inc. | 0.8219 |
| Kezar Life Sciences, Inc. | 7.29 |
| Protara Therapeutics, Inc. | 2.33 |
| Clene, Inc. | 3.88 |
Price Related Metrics
| PEG Ratio | -1.244 |
| Price to Book Value | 19.48 |
| Earnings Yield | -7.24% |
| Market Cap | 12.27B |
| PEGY Ratio | -1.244 |